secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001104659-24-062503
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics shareholders approve all 11 proposals at 2024 AGM
----------------------------------------------------------------------

- Directors Kevin Lee (36.4M for) and Jose-Carlos Gutierrez-Ramos (35.0M for) re-elected.
- Advisory vote on executive compensation passed with 36.2M for, 1.2M against.
- Ratification of PwC as US and UK auditors approved with ~37.4M for each.
- Share allotment authorization and pre-emption rights disapplication passed with >32M for each.
- New articles of association adopted with 37.4M for, 15,138 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/tm2414682d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer